Private equity company 3i buys Alpharma's API unit for $395mm
Affiliates of venture capitalist 3i have agreed to purchase the active pharmaceutical ingredient business of Alpharma (drugs for humans and animals) for $395mm in cash ($365mm net of taxes, fees, and other expenses).
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com